ARVN
Arvinas Inc

1,740
Mkt Cap
$807.3M
Volume
795,228.00
52W High
$21.00
52W Low
$5.90
PE Ratio
-15.66
ARVN Fundamentals
Price
$12.58
Prev Close
$12.57
Open
$12.64
50D MA
$10.74
Beta
1.35
Avg. Volume
2.79M
EPS (Annual)
-$2.77
P/B
1.58
Rev/Employee
$612,558.14
Loading...
Loading...
News
all
press releases
Armistice Capital LLC Invests $4.12 Million in Arvinas, Inc. $ARVN
Armistice Capital LLC acquired a new stake in Arvinas, Inc. (NASDAQ:ARVN - Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 560,000...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Arvinas, Inc. (NASDAQ:ARVN) Receives Average Recommendation of "Hold" from Analysts
Shares of Arvinas, Inc. (NASDAQ:ARVN - Get Free Report) have been assigned an average rating of "Hold" from the twenty-three research firms that are currently covering the stock, Marketbeat reports...
MarketBeat·1d ago
News Placeholder
Velan Capital Investment Management LP Takes Position in Arvinas, Inc. $ARVN
Velan Capital Investment Management LP bought a new position in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) during the second quarter, according to its most recent 13F filing with the...
MarketBeat·3d ago
News Placeholder
22NW LP Acquires Shares of 413,533 Arvinas, Inc. $ARVN
22NW LP bought a new stake in Arvinas, Inc. (NASDAQ:ARVN - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The...
MarketBeat·5d ago
News Placeholder
52,980 Shares in Arvinas, Inc. $ARVN Acquired by SG Americas Securities LLC
SG Americas Securities LLC acquired a new stake in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) in the second quarter, according to the company in its most recent 13F filing with the SEC. The...
MarketBeat·13d ago
News Placeholder
Entropy Technologies LP Purchases Shares of 32,491 Arvinas, Inc. $ARVN
Entropy Technologies LP purchased a new stake in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The...
MarketBeat·15d ago
News Placeholder
Arvinas (NASDAQ:ARVN) Stock Price Down 7% - Should You Sell?
Arvinas (NASDAQ:ARVN) Stock Price Down 7% - Here's What Happened...
MarketBeat·23d ago
News Placeholder
Connor Clark & Lunn Investment Management Ltd. Takes Position in Arvinas, Inc. $ARVN
Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) during the second quarter, according to its most recent filing with the...
MarketBeat·23d ago
News Placeholder
Promising Biotech Stocks To Consider - November 18th
Danaher, Cidara Therapeutics, argenex, Vertex Pharmaceuticals, and Arvinas are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of...
MarketBeat·24d ago
News Placeholder
Arvinas (NASDAQ:ARVN) Shares Gap Up - Should You Buy?
Arvinas (NASDAQ:ARVN) Shares Gap Up - What's Next...
MarketBeat·24d ago

Latest ARVN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.